title: A data-analytic strategy for protein biomarker discovery: profiling of high-dimensional proteomic data for cancer detection.
abstract: With recent advances in mass spectrometry techniques, it is now possible to investigate proteins over a wide range of molecular weights in small biological specimens. This advance has generated data-analytic challenges in proteomics, similar to those created by microarray technologies in genetics, namely, discovery of 'signature' protein profiles specific to each pathologic state (e.g. normal vs. cancer) or differential profiles between experimental conditions (e.g. treated by a drug of interest vs. untreated) from high-dimensional data. We propose a data-analytic strategy for discovering protein biomarkers based on such high-dimensional mass spectrometry data. A real biomarker-discovery project on prostate cancer is taken as a concrete example throughout the paper: the project aims to identify proteins in serum that distinguish cancer, benign hyperplasia, and normal states of prostate using the Surface Enhanced Laser Desorption/Ionization (SELDI) technology, a recently developed mass spectrometry technique. Our data-analytic strategy takes properties of the SELDI mass spectrometer into account: the SELDI output of a specimen contains about 48,000 (x, y) points where x is the protein mass divided by the number of charges introduced by ionization and y is the protein intensity of the corresponding mass per charge value, x, in that specimen. Given high coefficients of variation and other characteristics of protein intensity measures (y values), we reduce the measures of protein intensities to a set of binary variables that indicate peaks in the y-axis direction in the nearest neighborhoods of each mass per charge point in the x-axis direction. We then account for a shifting (measurement error) problem of the x-axis in SELDI output. After this pre-analysis processing of data, we combine the binary predictors to generate classification rules for cancer, benign hyperplasia, and normal states of prostate. Our approach is to apply the boosting algorithm to select binary predictors and construct a summary classifier. We empirically evaluate sensitivity and specificity of the resulting summary classifiers with a test dataset that is independent from the training dataset used to construct the summary classifiers. The proposed method performed nearly perfectly in distinguishing cancer and benign hyperplasia from normal. In the classification of cancer vs. benign hyperplasia, however, an appreciable proportion of the benign specimens were classified incorrectly as cancer. We discuss practical issues associated with our proposed approach to the analysis of SELDI output and its application in cancer biomarker discovery.
authors.affiliation: Cancer Prevention Research Program, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave. N., Seattle, WA 98109-1024, USA. yyasui@fhcrc.org
authors.forename: Yutaka
authors.initials: Y
authors.lastname: Yasui
authors.forename: Margaret
authors.initials: M
authors.lastname: Pepe
authors.forename: Mary Lou
authors.initials: ML
authors.lastname: Thompson
authors.forename: Bao-Ling
authors.initials: BL
authors.lastname: Adam
authors.forename: George L
authors.initials: GL
authors.lastname: Wright
authors.forename: Yinsheng
authors.initials: Y
authors.lastname: Qu
authors.forename: John D
authors.initials: JD
authors.lastname: Potter
authors.forename: Marcy
authors.initials: M
authors.lastname: Winget
authors.forename: Mark
authors.initials: M
authors.lastname: Thornquist
authors.forename: Ziding
authors.initials: Z
authors.lastname: Feng
mesh_terms: D000465:Algorithms; D014408:Biomarkers, Tumor / Q000097:blood*; D003627:Data Interpretation, Statistical; D003937:Diagnosis, Differential; D006801:Humans; D008297:Male; D011470:Prostatic Hyperplasia / Q000097:blood / Q000175:diagnosis / Q000473:pathology; D011471:Prostatic Neoplasms / Q000097:blood / Q000175:diagnosis* / Q000473:pathology; D040901:Proteomics / Q000379:methods*; D012680:Sensitivity and Specificity; D019032:Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization / Q000379:methods / Q000706:statistics & numerical data
chemical_list: D014408:Biomarkers, Tumor